Search results for "Myocardial infarction"


 
Results 61 - 70 of about 316 for "Myocardial infarction".
Sort by: Relevance | Newest | Oldest

After PCI, 5-year revascularization, MACE rates higher in women than men

Researchers pooled patient-level data from 21 randomized trials of bare-metal and drug-eluting stents.
https://immattersacp.org/weekly/archives/2020/04/07/5.htm
7 Apr 2020

Dual therapy for afib after PCI may reduce bleeding risk better than triple therapy

Researchers reviewed four randomized controlled trials of 7,953 patients that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events after percutaneous coronary intervention (PCI).
https://immattersacp.org/weekly/archives/2020/03/17/4.htm
17 Mar 2020

Managing HIV with testing, prevention

Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020

Closing care gaps in adult congenital heart disease

Many patients who are congenital heart disease survivors face gaps as they transition out of pediatric care, leading to problems that might have been avoided had they received appropriate, continuous care.
https://immattersacp.org/archives/2020/03/closing-care-gaps-in-adult-congenital-heart-disease.htm
1 Mar 2020

Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide

Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020

Adding colchicine after MI may reduce cardiovascular events

While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019

Diuretics may be superior to ACE inhibitors for initial hypertension monotherapy

Angiotensin-converting enzyme (ACE) inhibitors appeared only modestly less effective than thiazide or thiazide-like diuretics, but the effect of initial monotherapy with the latter across the whole population could be substantial, the study authors concluded.
https://immattersacp.org/weekly/archives/2019/11/05/2.htm
5 Nov 2019

Managing patients with diabetes and heart failure

Good control of diabetes in the presence of heart failure includes appropriate HbA1c targets, metformin and comprehensive lifestyle change as first-line therapy, and a team approach.
https://immattersacp.org/archives/2019/11/managing-patients-with-diabetes-and-heart-failure.htm
1 Nov 2019

Metoprolol not effective for reducing time to COPD exacerbation

A randomized placebo-controlled trial, which was stopped early due to safety and futility concerns, found no significant between-group difference in median time to first exacerbation of chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2019/10/29/4.htm
29 Oct 2019

Three months after PCI, discontinuing aspirin associated with less bleeding than continued dual antiplatelet therapy

High-risk patients who were randomized to switch to ticagrelor plus placebo had similar rates of cardiovascular events as those who continued ticagrelor plus aspirin, an industry-funded trial found.
https://immattersacp.org/weekly/archives/2019/10/08/2.htm
8 Oct 2019

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next